AstraZeneca pledges further progress for healthcare environment in Vietnam

AstraZeneca pledges further progress for healthcare environment in Vietnam

AstraZeneca is strengthening local partnerships to unlock the power of science and improve access to healthcare. Atul Tandon, general director of AstraZeneca Vietnam, discussed with VIR’s Minh Anh about the vision and next steps.
AstraZeneca reinforces commitment to healthcare

AstraZeneca reinforces commitment to healthcare

Pharma giant AstraZeneca is solidifying its position as a pioneer in healthcare innovation in Vietnam.
AstraZeneca honoured with award from BritCham

AstraZeneca honoured with award from BritCham

AstraZeneca has been recognised by BritCham for its innovation in the healthcare sector in Vietnam.
AstraZeneca to build 1.5 billion USD cancer drug facility in Singapore

AstraZeneca to build 1.5 billion USD cancer drug facility in Singapore

British pharmaceutical company AstraZeneca announced on May 20 its intention to build a 1.5 billion USD facility in Singapore to produce new generation cancer treatment drugs.
AstraZeneca profit up on strong sales of cancer drugs

AstraZeneca profit up on strong sales of cancer drugs

British pharmaceutical giant AstraZeneca on Thursday said net profit jumped 21 percent in the first three months of the year thanks to strong growth in sales of cancer drugs.
Advancements in chronic obstructive lung disease treatment and control

Advancements in chronic obstructive lung disease treatment and control

Conferences themed “Key to achieving triple goals in chronic obstructive pulmonary disease treatment in Vietnam” have taken place in Ho Chi Minh City and Hanoi.
Vietnam Minister of Planning and Investment visits AstraZeneca China

Vietnam Minister of Planning and Investment visits AstraZeneca China

A delegation led by Minister for Planning and Investment Nguyen Chi Dung has visited the AstraZeneca Global (R&D) China Centre.
AstraZeneca buys French biotech firm Amolyt for $1 bn

AstraZeneca buys French biotech firm Amolyt for $1 bn

Anglo-Swedish pharmaceuticals giant AstraZeneca on Thursday agreed to buy French biotech specialist Amolyt Pharma for about $1 billion, expanding further into the field of rare drugs.
AstraZeneca, VYPA sign MOU to enhance healthcare in Vietnam

AstraZeneca, VYPA sign MOU to enhance healthcare in Vietnam

AstraZeneca Vietnam and the Vietnam Young Physicians Association have signed an MoU on future cooperation.
Health Innovation Network launched in Vietnam

Health Innovation Network launched in Vietnam

The Vietnam Young Physicians Association and AstraZeneca Vietnam hosted a ceremony in Ho Chi Minh City on November 19 to launch the Health Innovation Network.
Healthy Lung Programme marks milestones

Healthy Lung Programme marks milestones

On November 3, an event on healthy lung health was held.
AstraZeneca advances lung cancer portfolio

AstraZeneca advances lung cancer portfolio

AstraZeneca showcased its lung cancer portfolio at the 2023 World Conference on Lung Cancer (WCLC) that was held in Singapore from September 9 to 12.
MoH and AstraZeneca expand health partnership

MoH and AstraZeneca expand health partnership

AstraZeneca has taken its long-term partnership with Vietnam’s Ministry of Health to the next level for a resilient and healthy local population.
AstraZeneca strengthens partnerships for health and gender equality

AstraZeneca strengthens partnerships for health and gender equality

Sylvia Varela, Asia Area vice president at AstraZeneca, spoke to VIR’s Bich Thuy about how AstraZeneca is pushing for gender equality in Vietnam.
Pharma giant extends partnership with Cho Ray Hospital

Pharma giant extends partnership with Cho Ray Hospital

AstraZeneca Vietnam and Cho Ray Hospital have signed an MoU to continue their commitment to improving healthcare.
|< < 1 2 3 4 > >|